Microfluidic Flows Enter Medical Mainstream
Microfluidic Readouts Could Flag Problems and Open the Door for New Treatment and Potential Early Intervention
Teasing Out Circulating Tumor DNA
New Advances Suggest That the Warning Attached to Many Biofluid-Based Diagnostic Tests May Be Temporary
Downstream Processing Builds Pure Intensity
Bioprocessing Favors Go with the Flow over Stop and Go
Tumor Biomarkers Culled from Errant Transcripts
Potential for Blood Platelet–Derived Biomarkers to ID and Locate Tumors
For full access to this article login to GEN Select now.
SAFC Expands to Meet Customer Demands
Firm Focuses on Technology Upgrades and QA/QC for Increasingly Specialized Products
- Suppliers to the biotechnology market, like Sigma-Aldrich’s SAFC division, are kept on their toes by constantly evolving customer demands. As a result, vendors have built larger and larger catalogs of products, moving into complex and challenging areas over the years. Diversity has been a fundamental component of SAFC’s ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.